Relevance of hairless mouse as an experimental model of percutaneous penetration in man

Skin Pharmacology and Applied Skin Physiology

Volumn 11, Issue 2, 1998, Pages 80-86

  Simon, Gad A ^a   Maibach, Howard I ^b  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hairless mouse; Model; Skin penetration

Indexed keywords

CORTICOSTEROID; LIDOCAINE;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; DRUG PENETRATION; EXPERIMENTAL MODEL; NONHUMAN; NUDE MOUSE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN PENETRATION; STRAIN DIFFERENCE;

ADRENAL CORTEX HORMONES; ANIMALS; HUMANS; MICE; MICE, INBRED HRS; MICE, NUDE; MODELS, BIOLOGICAL; NITROGLYCERIN; PERMEABILITY; SKIN ABSORPTION; SPECIES SPECIFICITY;

EID: 0031750460     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029812     Document Type: Article

References (47)

1. Gordon G: Variety of the common or house mouse. Zoologist 1850;8: 2763-2764.
2. Bateson W: Materials for the Study of Variation Treated with Special Regard to Discontinuity in the Origin of Species. New York, MacMillan, 1984, p 56.
3. Campbell A: Mus musculus var. M. nudo-plicatus. Zoologist 1907; 11:1-3.
4. Brooke HC: Hairless mice. J Hered 1926;17:173-174.
5. Summer FB: Hairless mice. J Hered 1924;15:475-481.
6. Montagna W, Chase HB, Melaragno HP: The skin of the hairless mice. I. The formation of cysts and the distribution of lipids. J Invest Dermatol 1952;19:83-94.
7. Görttler K, Friedmann W: Structural changes in the back skin of hr/hr mice throughout life (in German). Arch Klin Exp Dermatol 1971;237: 635-651.
8. Rigdon RH, Packchanian AA: Histologic study of the skin of congenitally athymic 'nude' mice. Texas Rep Biol Med 1974;32:711-723.
9. Orwin DFG, Chase HB, Silver AF: Catagen in the hairless house mouse. Am J Anat 1967;121:489-508.
10. Kadanoff D: Structural differences between the skin of hairless mice and the scalp skin of bald men (in German). Verb Anat Ges 1976;70: 483-489.
11. Snell GD: Inheritance in the house mouse, the linkage relations of short-ear, hairless, and naked. Genetics 1931;16:42-74.
12. Crew FAE, Mirskaia L: The character 'hairless' in the mouse, J Genet 1931;25:17-24.
13. Chase HB, Montagna W: The development and consequences of hairlessness in the mouse. Genetics 1952;37:537.
14. Flanagan SP: 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res (Cambridge) 1966;8:295-309.
15. Pantelouris EM: Absence of thymus in a mouse mutant. Nature 1968; 217:370-371.
16. Howard A: 'Rhino', an allele of hairless in the house mouse. J Hered 1940;31:467-470.
17. Gates AH, Arundell FD, Karasek MA: Hereditary defect of the pilose-baceous unit in a new double mutant mouse. J Invest Dermatol 1969; 52:115-118.
18. Stelzner KF: Four dominant autosomal mutations affecting skin and hair development in the mouse. J Hered 1983;74:193-196.
19. Fogh J, Giovanella BC: The Nude Mouse in Experimental and Clinical Research. New York, Academic Press, 1978.
20. rh) mutations, chromosome 14; in Sundberg JP (ed): Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models and Biomedical Tools. Boca Raton, CRC Press, 1994, chapt 22, pp 291-312.
21. Haigh JM, Smith EW: The selection and use of natural and synthetic membranes for in vitro diffusion experiments. Eur J Pharmacol Sci 1994;2:311-330.
22. Tsuruta H: Skin absorption of organic solvent vapors in nude mice in vivo. Ind Health 1989;27:37-47.
23. Reifenrath WG, Chellquist EM, Shipwash EA, Jederberg WW, Krueger GG: Percutaneous penetration in the hairless dog, weanling pig and grafted athymic nude mouse: Evaluation of models for predicting skin penetration in man. Br J Dermatol 1984;111:(suppl 27): 123-135.
24. Ridout G, Houk J, Guy RH, Santus GC, Hadgraft J, Hall LL: An evaluation of structure-penetration relationships in percutaneous absorption. Farmaco 1992;47:869-892.
25. Behl CR, Flynn GL, Kurihara T, Harper N, Smith W, Higuchi WI, Ho NFH, Pierson CL: Hydration and percutaneous absorption. I. Influence of hydration on alkanol permeation through hairless mouse skin. J Invest Dermatol 1980;75: 346-352.
26. Lambert WL, Higuchi WI, Knutson K, Krill SL: Effects of long-term hydration leading to the development of polar channels in hairless mouse stratum corneum. J Pharm Sci 1989; 78:925-928.
27. Stoughton RB: Animal models for in vitro percutaneous absorption; in Maibach HI (ed): Animal Models in Dermatology: Relevance to Human Dermatopharmacology and Dermatotoxicology. Edinburgh, Churchill Livingstone, 1975, chapt 12, pp 121-132.
28. Dürrheim H, Flynn GL, Higuchi WI, Behl CR: Permeation of hairless mouse skin. I. Experimental methods and comparison with human epidermal permeation by alkanols. J Pharm Sci 1980;69:781-786.
29. Flynn GL, Dürrheim H, Higuchi WI: Permeation of hairless mouse skin. II. Membrane sectioning techniques and influence on alkanol permeability. J Pharm Sci 1981;70:52-65.
30. Behl CR, Flynn GL, Linn EE, Smith WM: Percutaneous absorption of corticosteroids: Age, site, and skin-sectioning influences on rates of permeation of hairless mouse skin by hydrocortisone. J Pharm Sci 1984; 73:1287-1290.
31. Hou SYE, Flynn GL: Enhancement of hydrocortisone permeation of human and hairless mouse skin by 1-dodecylazacycloheptan-2-one. J Invest Dermatol 1989;93:774-779.
32. Van Den Hoven WE, Van Den Berg TP, Korstanje C: The hairless mouse as a model for the study of local and systemic atrophogenic effects following topical application of corticosteroids. Acta Derm Venereol (Stockh) 1991;71:29-31.
33. Bronaugh RL, Stewart RF, Congdon ER: Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 1982;62:481-488.
34. Huq AS, Ho FH, Husari N, Flynn GL, Jetzer WE, Condie L Jr: Permeation of water contaminative phenols through hairless mouse skin. Arch Environ Contam Toxicol 1986;15:557-566.
35. Hinz RS, Lorence CR, Hodson CD, Mansch C, Hall LL, Guy RH: Percutaneous penetration of para-substituted phenols in vitro. Fund Appl Toxicol 1991;17:575-583.
36. Kikkoji T, Gumbleton M, Higo N, Guy RH, Benez LZ: Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro. Pharmacol Res 1991;8:1231-1237.
37. Higo N, Hinz RS, Lau DTW, Benez LZ, Guy RH: Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin. Pharmacol Res 1992;9:187-190.
38. Higo N, Hinz RS, Lau DTW, Benez LZ, Guy GH: Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement. Pharmacol Res 1992;9:30 3-306.
39. Green PG, Hinz RS, Kim A, Szoka FC Jr, Guy RH: Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharmacol Res 1991;8:1121-1127.
40. Halkier-Sørensen L, Menon GK, Elias PM, Thestrup-Pedersen K, Feingold KR: Cutaneous barrier function after cold exposure in hairless mice: A model to demonstrate how cold interferes with barrier homeostasis among workers in the fish-processing industry. Br J Dermatol 1995;132:391-401.
41. Carelli V, Di Colo G, Nannipieri E, Serafini MF: Enhancement effects in the permeation of alparazolam through hairless mouse skin. Int J Pharm 1992;88:89-97.
42. Hori M, Satoh S, Maibach HI, Guy RH: Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: Effect of enhancer lipophilicity. J Pharm Sci 1991;80:32-35.
43. Bond JR, Barry BW: Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: Hydration damage. J Invest Dermatol 1988;90:486-489.
44. Bond JR, Barry BW: Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin. J Invest Dermatol 1988;90:810-813.
45. Kushla GP, Zatz JL: Influence of pH on lidocaine penetration through human and hairless mouse skin in vitro. Int J Pharm 1991;71: 167-173.
46. Rigg PC, Barry BW: Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J Invest Dermatol 1990;94:235-240.
47. Wester RC, Maibach HI: Cutaneous pharmacokinetics: Ten steps to percutaneous absorption. Drug Metab Rev 1983;14:169-205.